{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:22:24Z","timestamp":1782512544961,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1378\/chest.126.6.1946","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T03:42:53Z","timestamp":1103082173000},"page":"1946-1953","source":"Crossref","is-referenced-by-count":80,"title":["Tiotropium Bromide"],"prefix":"10.1016","volume":"126","author":[{"given":"Nicholas J.","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.6.1946_bib1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.96.5.984","article-title":"Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison to normal","volume":"96","author":"Gross","year":"1989","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/ajrccm\/146.3.555","article-title":"Acute bronchodilator trials in chronic obstructive pulmonary disease","volume":"146","author":"Nisar","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.6.1946_bib3","series-title":"Global Initiative for Chronic Obstructive Lung Disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2003 update","year":"2003"},{"key":"10.1378\/chest.126.6.1946_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM198808253190806","article-title":"Ipratropium bromide","volume":"319","author":"Gross","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.6.1946_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0163-7258(03)00004-4","article-title":"Muscarinic acetylcholine receptors and airway diseases","volume":"98","author":"Coulson","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1378\/chest.126.6.1946_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0024-3205(93)90312-Q","article-title":"Ba 679 BR, a novel long-acting anticholinergic bronchodilator","volume":"52","author":"Disse","year":"1993","journal-title":"Life Sci"},{"key":"10.1378\/chest.126.6.1946_bib7","first-page":"899","article-title":"Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping","volume":"45","author":"Haddad","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1378\/chest.126.6.1946_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0024-3205(98)00588-8","article-title":"Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease","volume":"64","author":"Disse","year":"1999","journal-title":"Life Sci"},{"key":"10.1378\/chest.126.6.1946_bib9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1164\/ajrccm.150.6.7952627","article-title":"Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways","volume":"150","author":"Takahashi","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000194092","article-title":"Immunological release of histamine from human lung: II. Studies on acetylcholine and the anticholinergic agent ipratropium bromide","volume":"38","author":"Morr","year":"1979","journal-title":"Respiration"},{"key":"10.1378\/chest.126.6.1946_bib11","first-page":"L970","article-title":"Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity","volume":"274","author":"Sato","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1378\/chest.126.6.1946_bib12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0954-6111(03)00162-8","article-title":"Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction","volume":"97","author":"Dahl","year":"2003","journal-title":"Respir Med"},{"key":"10.1378\/chest.126.6.1946_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1183\/09031936.02.00238002","article-title":"Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease","volume":"19","author":"van Noord","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib14","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1183\/09031936.95.08091506","article-title":"Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group","volume":"8","author":"Maesen","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/thorax.58.10.855","article-title":"Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"key":"10.1378\/chest.126.6.1946_bib16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1164\/ajrccm.154.4.8887578","article-title":"Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma","volume":"154","author":"O\u2019Connor","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1378\/chest.115.4.957","article-title":"Efficacy of salmeterol xinafoate in the treatment of COPD","volume":"115","author":"Mahler","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1164\/ajrccm.161.4.9903044","article-title":"Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease","volume":"161","author":"Littner","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Dutch\/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr\u2019s treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1378\/chest.122.1.47","article-title":"A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol","volume":"122","author":"Donohue","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"key":"10.1378\/chest.126.6.1946_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.123.5.1441","article-title":"Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses","volume":"123","author":"Tashkin","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.160.2.9901038","article-title":"Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease","volume":"160","author":"O\u2019Donnell","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1164\/ajrccm.162.1.9909054","article-title":"Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease","volume":"162","author":"Taube","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198408163110701","article-title":"Role of the parasympathetic system in airway obstruction due to emphysema","volume":"311","author":"Gross","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.6.1946_bib27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/ajrccm.163.6.2003172","article-title":"Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease","volume":"163","author":"Marin","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib28","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1378\/chest.124.5.1743","article-title":"Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes","volume":"124","author":"Celli","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD","volume":"23","author":"O\u2019Donnell","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib30","first-page":"A149","article-title":"Comparison of maintenance tiotropium and salmeterol on arterial blood gas tensions in patients with COPD [abstract]","volume":"48","author":"Gross","year":"2003","journal-title":"Respir Care"},{"key":"10.1378\/chest.126.6.1946_bib31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/ajrccm\/136.5.1091","article-title":"Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with COPD, comparison with a \u03b2-adrenergic agent","volume":"136","author":"Gross","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.6.1946_bib32","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1164\/ajrccm.160.3.9812117","article-title":"Effects of salmeterol on arterial blood gases of patients with stable COPD, comparison with albuterol and ipratropium","volume":"160","author":"Khoukaz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0895-4356(02)00589-9","article-title":"Meaningful effect size and patterns of response of the transition dyspnea index","volume":"56","author":"Witek","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1378\/chest.126.6.1946_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","article-title":"Minimal important difference of the transition dyspnoea index in a multinational clinical trial","volume":"21","author":"Witek","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib36","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure for chronic airflow limitation: the St George\u2019s Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.6.1946_bib37","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/thorax.56.11.880","article-title":"Health status measurement in chronic obstructive pulmonary disease","volume":"56","author":"Jones","year":"2001","journal-title":"Thorax"},{"key":"10.1378\/chest.126.6.1946_bib38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.6.1946_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36)","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1378\/chest.126.6.1946_bib40","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib41","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators","volume":"154","author":"Connors","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1378\/chest.126.6.1946_bib43","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1378\/chest.121.5.1449","article-title":"Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD","volume":"121","author":"Miravitlles","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.126.6.1946_bib44","first-page":"A207","article-title":"Reduced COPD exacerbations and associated health care utilization with once-daily tiotropium in the VA medical system [abstract]","volume":"169","author":"Niewoehner","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib45","first-page":"A519","article-title":"Tiotropium maintenance therapy and the additive effects of a single dose of ipratropium bromide or fenoterol in patients with COPD [abstract]","volume":"169","author":"Kerstjens","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib46","first-page":"A95","article-title":"Tiotropium maintenance therapy in patients with COPD and the 24-h spirometric benefit of adding once or twice daily formoterol during 2-week treatment periods [abstract]","volume":"167","author":"Van Noord","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib47","first-page":"A320","article-title":"Comparison of once daily tiotropium, twice daily formoterol and the free combination, once daily, in patients with COPD [abstract]","volume":"167","author":"Van Noord","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.6.1946_bib48","first-page":"140s","article-title":"Tiotropium is effective in patients with GOLD stage I disease (mild COPD) [abstract]","volume":"122","author":"Briggs","year":"2002","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921531446X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921531446X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:03:42Z","timestamp":1682892222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921531446X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S001236921531446X"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.6.1946","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}